Pharming (PHAR) Inventory (2019 - 2026)

Pharming's Inventory history runs 8 years deep, the most recent figure standing at $64.6 million for Q1 2026.

• Quarterly Inventory rose 8.81% year-over-year to $64.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.6 million (up 8.81% YoY) and the FY2025 annual result came in at $64.9 million, up 16.47% from the prior year.
• Inventory was $64.6 million for Q1 2026 at Pharming, down from $64.9 million in the prior quarter.
• Across five years, Inventory topped out at $67.1 million in Q3 2025 and bottomed at -$4.3 million in Q4 2023.
• A 5-year average of $45.0 million and a median of $55.7 million in 2024 frame the typical range for Inventory.
• Annual changes were most pronounced in 2022 — Inventory plunged 7250.34% — and 2023, when it jumped 159390.84%.
• Pharming's Inventory stood at -$2.0 million in 2022, then sank by 116.95% to -$4.3 million in 2023, then surged by 1403.18% to $55.7 million in 2024, then gained by 16.47% to $64.9 million in 2025, then slipped by 0.5% to $64.6 million in 2026.
• Business Quant data shows PHAR's Inventory at $64.6 million in Q1 2026, $64.9 million in Q4 2025, and $67.1 million in Q3 2025.